Follow me on Twitter
I agree that content from Twitter will be displayed to me.
Head of Group
Director of Corporate Program
His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.
Publications
Showing entries 296 - 300 out of 328
Ecker, G, Csaszar, E, Plagens, B, Holzer, W, Ernst, W & Chiba, P 2002, 'Identification of ligand-binding regions of P-glycoprotein by activated-pharmacophore photoaffinity labeling and matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry', Molecular Pharmacology, vol. 61, no. 3, pp. 637-648. https://doi.org/10.1124/mol.61.3.637
Klein, C, Kaiser, D, Kopp, S, Chiba, P & Ecker, G 2002, 'Similarity based SAR (SIBAR) as tool for early ADME profiling', Journal of Computer-Aided Molecular Design, vol. 16, no. 11, pp. 785-793. https://doi.org/10.1023/A:1023828527638
Chiba, P, Erker, T, Galanski, M & Ecker, G 2002, 'Synthesis and multidrug-resistance modulating activity of a series of thienothiazines', Archiv der Pharmazie, vol. 335, no. 5, pp. 223-228.
Ecker, G 2002, 'Troxacitabine (Shire Pharmaceuticals).', Current Opinion in Investigational Drugs, vol. 3, no. 10, pp. 1533-1538.
Ecker, G, Kalchhauser, H, Lawtrakul, L & Wolschann, KP 2001, 'Levcromakalim Revisited: NMR Spectroscopic and Theoretical Investigations', Monatshefte für Chemie, vol. 132, no. 3, pp. 373-386. https://doi.org/10.1007/s007060170123
Projects
Molecular Drug Targets
Hering, S. (Project Lead), Ecker, G. (Co-Lead), Maulide, N. (Co-Lead), Weinzinger, A. (Co-Lead) & Gonzalez Herrero, L. (Co-Lead)
1/12/10 → 31/12/22
Project: Research funding